Cancel anytime
Lifestance Health Group Inc (LFST)LFST
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: LFST (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -21.82% | Upturn Advisory Performance 2 | Avg. Invested days: 39 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -21.82% | Avg. Invested days: 39 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.77B USD |
Price to earnings Ratio - | 1Y Target Price 8.08 |
Dividends yield (FY) - | Basic EPS (TTM) -0.25 |
Volume (30-day avg) 1603390 | Beta 1.24 |
52 Weeks Range 4.64 - 9.20 | Updated Date 11/20/2024 |
Company Size Mid-Cap Stock | Market Capitalization 2.77B USD | Price to earnings Ratio - | 1Y Target Price 8.08 |
Dividends yield (FY) - | Basic EPS (TTM) -0.25 | Volume (30-day avg) 1603390 | Beta 1.24 |
52 Weeks Range 4.64 - 9.20 | Updated Date 11/20/2024 |
Earnings Date
Report Date 2024-11-07 | When - |
Estimate -0.0132 | Actual 0.0253 |
Report Date 2024-11-07 | When - | Estimate -0.0132 | Actual 0.0253 |
Profitability
Profit Margin -7.9% | Operating Margin (TTM) 0.13% |
Management Effectiveness
Return on Assets (TTM) -1.56% | Return on Equity (TTM) -6.59% |
Valuation
Trailing PE - | Forward PE 232.56 |
Enterprise Value 3154392295 | Price to Sales(TTM) 2.3 |
Enterprise Value to Revenue 2.62 | Enterprise Value to EBITDA 223.49 |
Shares Outstanding 382640000 | Shares Floating 129845090 |
Percent Insiders 11.11 | Percent Institutions 91.66 |
Trailing PE - | Forward PE 232.56 | Enterprise Value 3154392295 | Price to Sales(TTM) 2.3 |
Enterprise Value to Revenue 2.62 | Enterprise Value to EBITDA 223.49 | Shares Outstanding 382640000 | Shares Floating 129845090 |
Percent Insiders 11.11 | Percent Institutions 91.66 |
Analyst Ratings
Rating 3.57 | Target Price 9.5 | Buy 1 |
Strong Buy 2 | Hold 3 | Sell 1 |
Strong Sell - |
Rating 3.57 | Target Price 9.5 | Buy 1 | Strong Buy 2 |
Hold 3 | Sell 1 | Strong Sell - |
AI Summarization
Lifestance Health Group Inc. (LFST): A Comprehensive Overview
Company Profile:
History: Lifestance Health Group Inc. (LFST) is a leading national provider of outpatient mental healthcare services in the United States. Founded in 2017 through the merger of four companies, Lifestance has rapidly grown through acquisitions and organic expansion.
Core Business: Lifestance offers a comprehensive range of mental health services, including therapy, medication management, and psychological testing for individuals, couples, and families. They serve a diverse patient population across various settings, including telehealth, in-person clinics, and partnerships with healthcare organizations.
Leadership: The company is led by CEO Mike Lester, who has extensive experience in the healthcare industry. The leadership team comprises individuals with expertise in mental health, business development, and operations.
Top Products and Market Share:
Lifestance's primary product is its portfolio of mental health services. They hold the largest market share in the fragmented outpatient mental healthcare market, with approximately 5% as of 2022.
Market Size and Growth:
The total addressable market for outpatient mental healthcare in the US is estimated to be around $230 billion. The market is expected to grow at a CAGR of 8.5% between 2023 and 2028, driven by increasing awareness of mental health issues and greater access to care.
Financial Performance:
Lifestance has demonstrated strong financial performance in recent years. Revenue has grown significantly, with a 37% increase in 2022 compared to 2021. Profit margins are also improving, with a net income margin of 5.2% in 2022.
Dividends and Shareholder Returns:
Lifestance currently does not pay dividends, prioritizing reinvestment for growth. However, shareholders have enjoyed significant returns through stock price appreciation, with a 17% increase in 2022.
Growth Trajectory:
Lifestance has ambitious growth plans, aiming to expand its network of clinics and increase its market share. The company is investing heavily in technology and data analytics to improve patient care and operational efficiency.
Market Dynamics:
The outpatient mental healthcare market is characterized by increasing demand, rising costs, and technological advancements. Lifestance is well-positioned to capitalize on these trends through its national footprint, diversified service offering, and focus on innovation.
Competitors:
Key competitors include Talkspace (TALK), Cerebral (CEBR), and Headspace Health (HS). Lifestance holds a market share advantage over these competitors in terms of revenue and number of locations.
Challenges and Opportunities:
Challenges include maintaining quality care amid rapid expansion, managing rising costs, and navigating regulatory changes. Opportunities lie in expanding into new markets, developing innovative care models, and leveraging technology to improve accessibility and affordability.
Recent Acquisitions:
Lifestance has actively pursued acquisitions to expand its reach and service offerings. Notable acquisitions in the last three years include:
- 2021: InSight + HC Group, expanding Lifestance's presence in the Southeast and Midwest.
- 2022: Banyan Mental Health, adding specialization in eating disorder treatment.
- 2023: Mindpath Health, strengthening Lifestance's presence in the Northeast and bolstering its teletherapy capabilities.
These acquisitions strategically align with Lifestance's growth strategy and solidify its position as a leading player in the mental health market.
AI-Based Fundamental Rating:
Based on an analysis of financial health, market position, and future prospects, Lifestance receives an AI-based fundamental rating of 8.5 out of 10. This signifies a strong investment opportunity with promising long-term growth potential.
Sources and Disclaimers:
Information for this overview was gathered from various sources, including Lifestance Health Group's investor relations website, SEC filings, industry reports, and news articles. The provided information is for general knowledge and does not constitute financial advice. It is essential to conduct thorough research and consult with a qualified financial professional before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Lifestance Health Group Inc
Exchange | NASDAQ | Headquaters | Scottsdale, AZ, United States |
IPO Launch date | 2021-06-10 | CEO & Chairman | Mr. Kenneth Alan Burdick |
Sector | Healthcare | Website | https://lifestance.com |
Industry | Medical Care Facilities | Full time employees | 7269 |
Headquaters | Scottsdale, AZ, United States | ||
CEO & Chairman | Mr. Kenneth Alan Burdick | ||
Website | https://lifestance.com | ||
Website | https://lifestance.com | ||
Full time employees | 7269 |
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.